WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Pre-Market Charts NEWS & ANALYSIS News Press Releases Analyst Research Key... WebMar 30, 2024 · Upon closing of the transactions, Citius would continue to trade on the Nasdaq exchange under its current ticker CTXR. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale ...
Citius Pharmaceuticals, Inc. (CTXR) - Yahoo!
WebFeb 20, 2024 · Citius Pharmaceuticals (Ticker: $CTXR) is only a couple months away from anticipated positive Phase 3 results for its lead product Mino-Lok. However, with its $2 share price, it has a modest... WebFeb 17, 2024 · Learn more about Citius Pharmaceuticals Inc's (CTXR) stock grades for Momentum, Growth and Estimate Revisions and determine whether this Biotechnology & Medical Research stock meets your investment needs. Sean Murphy > Latest News. Maxim Group Sticks to Its Buy Rating for Citius Pharmaceuticals (CTXR) ... bioswing souillac
CTXR Stock Forecast, Price & News (Citius …
WebCTXR Complete Citius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebApr 6, 2024 · A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … Web$CTXR- Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. Product pipeline: Mino-Lok® - Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections (CRBSIs). bioswing schwingstab improve 150